Hemasource Indianapolis, IN - 46204

Hemasource is categorized under Wholesale Pharmaceutical Products in Indianapolis, IN and active since 1997.

Hemasource was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact Tom Anderson, Owner at the company’s single location by writing to 1060 North Capitol Avenue # E299, Indianapolis, Indiana IN 46204 or by phoning (317) 955-8770. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Hemasource
Contact Person: Tom Anderson, Owner
Address: 1060 North Capitol Avenue # E299, Indianapolis, Indiana 46204
Phone Number: (317) 955-8770
Website Address: hemasource.net
Annual Revenue (USD): $500.000 to $999.999
Founded: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 4461100
Share This Business:

Hemasource was started in 1997 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Tom Anderson, Owner for inquiries that concern Hemasource by calling the company number (317) 955-8770, as your correspondence is most welcome. Additionally, the physical location of the single location of Hemasource can be found at the coordinates 39.782318,-86.161273 as well as the street address 1060 North Capitol Avenue # E299 in Indianapolis, Indiana 46204.

For its online presence, you may visit Hemasource’s website at hemasource.net and engage with its social media outlets through on Twitter and on Facebook.